The company revealed the hike in profits was as a result of a series of new business wins, in addition to improvements and investments made in IT and infrastructure.
Zibrant experienced a decline in gross profit by 11% to £9.3m last year, but explained overheads were £1.2m lower, returning to normal levels after the major IT investments in 2011.
Fay Sharpe, managing director at Zibrant, said: "We invested heavily in IT and our service delivery with the objective that this would deliver efficiencies and would maximise our value proposition.
"Everyone in the business has strived hard to implement these changes and we are now seeing the benefits coming through."
She added that Zibrant was confident that 2013 would be another good year for the company, due to achieving cost reductions and revenues boosted by a series of major account wins.
In 2012, Zibrant was awarded three multi-million pound sole supplier contracts to help bolster its presence within the pharmaceutical and legal sectors. The business noted a series of new contract wins during the first quarter of 2013. They include a leading healthcare business specialising in oncology and nephrology, based in Cambridge.
Comment below to let us know what you think.
For more in-depth and print-only features, showcases and interviews with world-leading brands, don't miss the next issue of Event magazine by